Tammy Bilunka is a Hermitage, Pennsylvania based counselor who is specialized as Addiction (Substance Use Disorder) Counselor. Her current practice location is 941 N Water Ave, Hermitage. Patients can book an appointment with her at 800-262-4626.
Tammy Bilunka is a licensed mental health therapist who help individuals struggling with addiction of alcohol, drug, or other substance use disorder. She helps her clients by manage and overcome the psychological, emotional, and behavioral challenges related to substance use. Counselors also work closely with families and support systems to help them better understand their loved one’s illness. SUD counselors help to promote long-term sobriety, emotional stability, and overall mental wellness for both the individual and their family.
Complete Profile:
Tammy Bilunka speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Tammy Bilunka
Specialization:
Addiction (Substance Use Disorder) Counselor
Gender:
Female
Accepts Medicare Assignment:
No
Practice Address:
941 N Water Ave, Hermitage, Pennsylvania, 16148-1106
Phone:
800-262-4626
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1649869140
NPI Enumeration Date:
11 Jan, 2021
NPI Last Update On:
11 Jan, 2021
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
941 N Water Ave, Hermitage, Pennsylvania
Zip:
16148-1106
Patients can reach Tammy Bilunka at 941 N Water Ave, Hermitage, Pennsylvania or can call to book an appointment on 800-262-4626. *Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 June, 2025.